Skip to main content
Premium Trial:

Request an Annual Quote

NIAID to Fund Nonhuman Primate Genomics Lab for AIDS Studies

NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases plans to fund one contractor to run a lab that will conduct genomics activities to support its Simian Vaccine Evaluation Unit, or SVEU, contract sites and research funded through its Division of Acquired Immune Deficiency Syndrome, or DAIDS.

The Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccine Research and Development will use and improve assays to generate quantitative genomic expression profiles and network diagrams from RNA samples, NIAID said in a recent notice.

The contractor will be responsible for compiling and analyzing data from NHP research projects using bioinformatics and biocomputing tools.

NIAID expects to fund a contract for a one-year base period and four one-year options for a total of up to five years, beginning in the summer of 2013.

The functional genomics lab will join three existing NHP facilities, including the Cellular Immunology Core Lab, the Viral Ribonucleic Acid Core Lab, and the Humoral Immunology Core Lab, and it will be tasked with insuring standardization and comparability of functional genomics services and assays conducted for the SVEU and DAIDS-supported clinical studies.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.